Absolute iron deficiency, coronary artery calcification and cardiovascular mortality in maintenance haemodialysis

Sonoo Mizuiri1, Yoshiko Nishizawa1, Kazuomi Yamashita1

  • 1Division of Nephrology, Ichiyokai Harada Hospital, Hiroshima, Japan.

PubMed

Insights

Absolute iron deficiency in maintenance haemodialysis patients is linked to higher coronary artery calcification and increased cardiovascular mortality. This study highlights iron status as a critical factor in vascular health for dialysis patients.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Hematology

Background:

  • Clinical studies on iron's role in vascular calcification are limited, despite preclinical evidence.
  • Vascular calcification and associated mortality are significant concerns in patients undergoing maintenance haemodialysis (MHD).
  • Understanding iron status in MHD patients is crucial for managing cardiovascular risk.

Purpose of the Study:

  • To investigate the association between absolute iron deficiency and coronary artery calcification (CACS) in MHD patients.
  • To examine the relationship between absolute iron deficiency and 3-year mortality (all-cause and cardiovascular) in MHD patients.
  • To identify iron deficiency markers as predictors of CACS and mortality in this population.

Main Methods:

  • A cohort of 306 maintenance haemodialysis patients was studied.
  • Baseline measurements included transferrin saturation (TSAT), ferritin, mean corpuscular haemoglobin (MCH), and Agatston coronary artery calcium score (CACS).
  • Patients were followed for 3 years for mortality; Cox proportional hazard and linear regression analyses were performed.

Main Results:

  • Patients with absolute iron deficiency (TSAT <20% and ferritin <100 ng/mL) exhibited significantly higher CACS and C-reactive protein levels.
  • Absolute iron deficiency independently predicted 3-year cardiovascular mortality (HR: 2.08, p=0.0466) but not all-cause mortality.
  • CACS, absolute iron deficiency, and MCH were significant predictors of CACS and mortality outcomes.

Conclusions:

  • Absolute iron deficiency is associated with increased coronary artery calcification in MHD patients.
  • Absolute iron deficiency serves as a significant risk factor for coronary artery calcification and 3-year cardiovascular mortality in MHD patients.
  • Iron status, specifically absolute iron deficiency, should be considered in the cardiovascular risk assessment of MHD patients.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
180
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.3K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
428
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
934